医学
透视
烧蚀
心房颤动
工作流程
导管消融
医学物理学
射频消融术
放射科
计算机科学
心脏病学
数据库
作者
Shaojie Chen,Sanjiv M. Narayan,Serge Bovéda,Kars Neven,Martin H. Ruwald,Martin Martinek,Piotr Futyma,Christian Meyer,Christian‐Hendrik Heeger,Philipp Sommer,Alexandra Schratter,Bart A. Mulder,Márcio Galindo Kiuchi,Pipin Kojodjojo,Jeremy Chow,Tsz Kin Tam,Zhijun Sun,Jingquan Zhong,Yuehui Yin,Boris Schmidt
标识
DOI:10.1161/circep.125.013977
摘要
Pulsed field ablation (PFA) has been developed as a largely nonthermal ablation technology with a unique biophysical profile to treat atrial fibrillation. Existing evidence has shown that PFA offers a safe and efficient atrial fibrillation ablation procedure. Among different PFA technologies, the pentaspline FARAPULSE system has been the most extensively used and investigated; however, notable variability exists in workflow, fluoroscopy time, and lesion durability. While innovations such as 3-dimensional electroanatomic mapping systems and intracardiac echocardiography can enhance procedural precision in catheter ablation, fluoroscopy remains the primary imaging modality for guiding pentaspline PFA in many electrophysiology labs worldwide. This is particularly true in centers where limitations in cost, infrastructure, or training may preclude the routine use of advanced imaging technologies. This article summarizes general practical considerations and presents a primarily fluoroscopy-based, refined workflow developed by a group of experts. The goal is to provide a procedural foundation and practical guide for using the pentaspline FARAPULSE PFA system in atrial fibrillation ablation procedures. Developing a fluoroscopy-based practical guide would: (1) Democratize access to PFA technology, enabling safe and effective implementation across a broader range of clinical settings, including those without intracardiac echocardiography or 3-dimensional mapping support; (2) Reduce procedural heterogeneity by offering reproducible best practices; (3) Facilitate meaningful intercenter comparisons of procedural efficacy and safety, aiding in the identification of optimal approaches and improving the quality of clinical data for ongoing research, registries, and real-world performance monitoring of PFA technologies; and (4) Ultimately improve patient outcomes through standardized, accessible, and evidence-based practices.
科研通智能强力驱动
Strongly Powered by AbleSci AI